Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

An Eli Lilly spokesperson told Pharmaceutical Technology: “[The telehealth companies] are deceptively marketing knockoff tirzepatide as safe and effective for ‘cosmetic weight loss ...

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s ...

Eli Lilly, facing mounting scrutiny in Congress over big increases in the list price ... Lilly says the price it was paid for popular insulin Humalog fell 8.1% from 2014 to 2018 due to increasing ...

Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers Approval would trigger new competition for Biogen and Eisai’s Leqembi Published: June 7, 2024 at 8:45 a.m. ET ...

The U.S. FDA has found new manufacturing lapses at Eli Lilly's (LLY) Branchburg, New Jersey plant, including potential cases of data manipulation. Read more here.

Lilly said in a government filing it was cooperating fully with the investigation. That investigation is ongoing. Lilly shares rose 0.37% Monday, to $630.88 each.

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s ...

Eli Lilly & Co.'s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug's blockbuster potential in the company's ...